Abstract: In 2012, Dr. Liao, Dr. Sandberg and Dr. Roache published an interesting research, aimed at suggesting a challenging solution to climate change based on genetic manipulation: smaller human beings would individually suit better environmental challenges. Although appealing, this theory quite soon reveals its weaknesses against a legal and bioethical landscape, as it would evidently clash with human rights and the principles of international bioethics and international biolaw. Drawing inspiration from the above-mentioned research, this paper assesses the interplay between climate change and bioethical and legal implications under international law. In this respect, the horizons of genome editing are considered against the background of the relevant international reference tools, as the UNESCO Universal Declaration on Human Genome and Human Rights and the Oviedo Convention, for advancing feasible solutions offered by therapeutic interventions on human somatic cells and epigenetics as means for improving human adaptation to the adverse effects of climate change.
INTRODUCTION
In 2012, Dr. Liao, Dr. Sandberg and Dr. Roache published an interesting research, aimed at suggesting an innovative -and challenging -solution to climate change based on genetic manipulation on future generations: smaller human beings would individually suit better environmental challenges and would make up a more eco-friendly society. The study also advanced several other solutions, capable of affecting personal life from different viewpoints, as administering pharmaceutical therapies in order to influence people's preference about food, lowering birth-rates through cognitive enhancement, The recognition of the interrelationship between climate change and human rights is a fundamental feature of the globally concerted approach undertaken by the international community. 8 This acknowledgment was restated many times, on the 5 "The Impact of Climate Change on Natural Disasters", Earth Observatory, NASA, available at https://earthobservatory.nasa.gov/Features/RisingCost/rising_cost5.php last accessed 16 October 2017. VIDAS, D., "The Earth in the Anthropocene and the World in the Holocene?", ESIL Reflections, 24 August 2015, 4(6), available at http://www.esil-sedi.eu/node/987 last accessed 6 October 2017. For deeper analysis of biotechnological risks affecting human security and of environmental risks, see CORTI VARELA, J. L., "Seguridad Humana ante nuevos riesgos biotecnológicos: entre la "cientificación" y la "politización"", Araucaria. Revista Iberoamericana de Filosofía, Política y Humanidades, n° 36, 2016, pp. 417-437. 6 UN General Assembly, United Nations Framework Convention on Climate Change: resolution/adopted by the General Assembly, 20 January 1994, A/RES/48/189, available at https://unfccc.int/resource/docs/convkp/conveng.pdf last accessed 13 October 2017. 7 Kyoto Protocol to the United Nations Framework Convention on Climate Change, UN Doc FCCC/CP/1997/7/Add.1, 10 December 1997; 37 ILM 22 (1998) , available at https://treaties.un.org/pages/ViewDetails.aspx?src=IND&mtdsg_no=XXVII-7-a&chapter=27&lang=en last accessed 12 October 2017. 8 GARCÍA SAN JOSÉ, D. I., Crisis económica, vulnerabilidad multidimensional y cambio climático: la "tormenta perfecta" para el derecho a la salud en europa, Bioderecho.es, Estudios de Vulnerabilidad, n. 5, 2017, available at http://revistas.um.es/bioderecho/article/view/290821 last accessed 10 October 2017; SÁNCHEZ PATRÓN, J. M., TORRES CAZORLA, M.I., GARCÍA SAN JOSÉ, D., Bioderecho, Seguridad y Medioambiente. Biolaw, Security and Environment, Tirant Lo Blanch, Valencia, For further information on UN Habitat Conferences, see the Official Website at https://unhabitat.org/habitat-iii-conference/. common goals are set and intended to be achieved together but leaving States a margin of discretion that fosters commitment proportionally to each nation's real capacity to bind itself to given objectives. The provision of nationally determined contributions (NCDs) is clear evidence for that. What is remarkable is that the Paris Agreement has not overlooked human rights: despite their protection is not provided as binding commitment for States Parties, a generalized and comprehensive human rights-based approach is promoted in the architecture of the Agreement.
Human rights are recalled in the Preamble, which entails strong moral value and persuasion and the reference made impacts the interpretation of the commitments that States have adopted from a broad perspective that goes beyond the Paris Agreement itself. In particular, the relevant statement " [a] cknowledg [es] that climate change is a common concern of humankind [therefore] Parties should, when taking action to address climate change, respect, promote and consider their respective obligations on human rights". It means that compliance with the obligations arising from the Paris Agreement has to result in the adoption of international and domestic policies and measures consistent with the protection of human rights, and capable of suiting the specific needs of the vulnerable groups which are subsequently cited in the text of the provision, as they are particularly exposed to the adverse effects of climate change. Echoing sustainability, the same statement of the Preamble also recalls the right to development and puts in evidence 'intergenerational equity'. 19 The wording of this clause is not without consequence: it founds a far-sighted approach that requires action that is both prompt and respectful of future generations. Action adopted today cannot prejudice future generations' rights and their conditions of life.
The reference to human rights made in the Paris Agreement, in line with the other previous tools cited above, is particularly significant: it implies that human rights amount to a basic component of States' action that addresses climate change. Including when the protection of the right to health and the right to science are at stake, and issues related to biotechnologies and epigenetics are no exceptions: in this respect, also the reference to the right to development and the call for protection of future generations assume particular relevance because, as clarified more in depth below, they can both benefit or being prejudiced by practical applications of scientific progress.
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As stressed above, despite the Paris Agreement does not impose specific human rights duties on States Parties, it recalls their "respective obligations on human rights": by so doing, besides elucidating the content of the morally persuasive exhortation it contains, the Agreement also frames the reference binding framework for each Party. In practice, the reference is to the universal and regional human rights treaties, both 19 Paris Agreement, Preamble. 20 See: AKEEM, A., "Genetic Engineering and Sustainable Development: A Philosophical Inquiry", International Conference on Environmental, Biomedical and Biotechnology IPCBEE vol.41 (2012) . generalist and thematic, to which States are bound under international law, and which include the instruments that are relevant for paving the way to the human-rights based approach to biotechnologies and epigenetics as means for fostering human adaptation to climate change theorized here in this study.
THE RESPONSE OF INTERNATIONAL BIOETHICS TO THE NEW HORIZONS OF BIOENGINEERING: STRIKING THE BALANCE BETWEEN ETHICS AND SCIENTIFIC PROGRESS
The necessary premise for the theorization of human rights States' duties related to bioengineering and epigenetics implies assessment of the solution advanced by Dr. Liao, Dr. Roache and Dr. Sandberg in light of the relevant international instruments. Therefore, the crucial point is assessing whether genome editing entailing human germline alterations is allowed under international law, in particular under the Universal Declaration on Human Genome and Human Rights 21 and the Convention on Human Rights and Biomedicine, 22 also known as the Oviedo Convention.
These two instruments marked two important steps for the international community in the field of biolaw twenty years ago. It is not a coincidence that both the Universal Declaration on Human Genome and Human Rights and the Oviedo Convention date back to 1997: the late 1990s and the early 2000s have been a fundamental moment in the history of biolaw and especially of human genome thanks to the Human Genome Project, that produced the first complete sequences of human genomes. 23 Again, it is not a coincidence that both instruments widely build upon the conception of human dignity, as a founding value and principle that permeates them. Both instruments are the result of a lively ethical debate on the impact of biomedicine on human rights that they take up and boost, and pursue the purpose of fostering harmonization of the different local landscapes in order to promote the development of scientific research and, at the same time, ensuring that progress keeps respectful of human dignity and the rights of the subjects involved. Indeed, the Universal Declaration on Human Genome and Human Rights and the Oviedo Convention build upon the acknowledged conception that human rights 'flow' from human dignity, 24 which provides them their ultimate justification and preserves them from possible abuses and misuses of scientific progress. This is all the more true when latest innovations in bioengineering may apply to human genome, which could lead to unpredictable outcomes and raises serious concerns of unethical practices, that serve human beings to mere scientific interests in breach of beneficence principle and of the primacy of human beings over the interests of science and society. 25 Before assessing more in-depth the approach adopted by the Universal Declaration on Human Genome and Human Rights and the Oviedo Convention, a distinction has to be made between the two feasible typologies of genome editing, namely interventions concerning human somatic cells alterations, that interest body cells and limit to the adult subject treated, and alterations of the human germline that, otherwise, affect oocyte, sperm and early embryos and are thus transmissible to the progeny. 26 While interventions on somatic cells are allowed when they pursue therapeutic and not human traits enhancement ends, 27 human germline alterations are prohibited under international law and by a wide number of national regulations, 28 due to the serious concerns related to the transmissibility of such modifications to future generations.
The Universal Declaration on the Human Genome and Human Rights expressly qualifies human germline alterations as contrary to human dignity, at Article 24.
29 This statement represents a specification of the constant reference to human dignity as the founding value aimed at underlying and guiding research in its developments, since human genome, in a symbolic sense, can be intended as heritage of mankind. This perspective is shared and restated also by the Oviedo Convention, whose Article 13 provides that "[a]n intervention seeking to modify the human genome may only be undertaken for preventive, diagnostic or therapeutic purposes and only if its aim is not to introduce any modification in the genome of any descendants", which appears as a specification of the statement contained in the Explanatory Report to the Oviedo Convention where, with reference to the Preamble, it is clarified that "the developments in medicine and biology […] should be used only for the benefit of present and future generations and not be diverted in ways that run counter to their proper objective". Scientific progress, indeed, cannot be diverted in order to suit unorthodox purposes, but has to serve always the "benefits of progress to the whole of mankind", a goal to pursue through international cooperation as the Explanatory Report clarifies, in line with the globalization of the challenges scientific evolution poses, especially in the bioethical field. The serious concerns of eugenic threats accounts for the perspective enshrined in the Oviedo Convention, as well as in the Universal Declaration on Human Genome and Human Rights, and explains the call for international debate and concerted action, as the only adequate context where to additionally ensure solidarity towards less developed and more vulnerable countries, that could be easier targets of unethical intents of experimentation.
An observation can be made quite promptly when the approach to human germline alterations adopted by the Universal Declaration on Human Genome and Human Rights and the Oviedo Convention is considered: in this case, law has anticipated scientific progress, which is definitely unusual in the field of biolaw, where it is common that law lags behind science. 30 In fact, scientific progress had not made remarkable steps ahead in 28 With regard to some domestic experiences, see: ANDORNO, R., "Biomedicine and international human rights law: in search of a global consensus", Bulletin of the World Health Organization, n° 80, 2002, pp. 959-963, recalling, for example, Brazil Law 8974/95. For wider analysis, see: ANDORNO, R., "Global bioethics at UNESCO: in defence of the Universal Declaration on Bioethics and Human Rights", Journal of Medical Ethics, n° 33 (3), 2007, pp. 150-154. 29 In particular, Article 24 of the UNESCO Universal Declaration on the Human Genome and Human Rights defines germline interventions as "contrary to human dignity". 138 relation to human germline alterations until the advent of the CRISPR/Cas9, a genome editing technique that enables scientists to eliminate and replace entire sections of DNA, with more precision and at more affordable costs than in the past. The CRISPR/Cas9 technique could be used on human embryos, which makes human germline alterations a possibility in scientific research which, nonetheless, would be at odds with the Universal Declaration on Human Genome and Human Rights and the Oviedo Convention. 31 What is more, a shift of perspective is unlikely. In October 2015, a UNESCO Panel of Experts launched a call for a temporary ban on human germline editing, which was followed by an appeal issued by some scientists for a general ban on human germline alterations through use of the CRISPR/Cas9 technique and similar techniques. A couple of months later, in December 2015 the Council of Europe's Committee on Bioethics adopted a Statement on Genome Editing Technologies 32 stressing the importance of the role of the Oviedo Convention for dealing with human germline interventions. In the same period, the Organizing Committee for the International Summit on Human Gene Editing, in which outstanding researchers in the field participated, published a summit statement where it did not exclude running in-vitro human germline genetic interventions. Some other scientists joined the debate arguing that in-vitro research implying human germline editing may be a feasible route. Nonetheless, these voices are still a minority in the international scientific and non-scientific community, which means that consensus on prohibition on human germline alterations is still unchanged. It is interesting to stress that prohibition on human germline interventions, along with the rejection of human cloning for reproductive purposes, represents an exceptional case where the international community has expressed a converging view in the field of biolaw, where usually a variety of perspectives are called to confront. For deeper analyis see ANDORNO, R., "Biomedicine and international human rights law: in search of a global consensus", cited above n. 28. Also see: ANDORNO, R., Principles of international biolaw. Seeking common ground at the intersection of bioethics and human rights, Bruylant, Bruxelles, 2013; HILDT, E., "Human Germline Interventions-Think First", Frontiers in Genetics, n° 7, Article n° 81, 2016. That being said, it appears quite clear that the thesis advanced by Dr. Liao, Dr. Roache and Dr. Sandberg would clash with the principles set out by international law in the field of human germline interventions transmissible to future generations. Nor reference to the less strict conception of the right to 'genetic identity', 34 which allows human germline modifications for the prevention of genetic disease, would lead to different conclusions. This entitlement builds upon the conception of human dignity, and protects future generations from alterations of their genetic structure caused by the intervention of precedent generations. The rationale underlying the protection of genetic identity lies basically in two justifications: firstly, as some authoritative scholarship has stressed, present generation do not have the right to genetically predetermine the features of future generation according to their contingent conception of is "good" or "bad". Moreover, some objections concern future generations' self-perception as "autonomous beings" and not mere objects or artefacts. A similar reasoning, along with the protection of parenthood, accounts for the prohibition of reproductive cloning as well. 35 Again, a major threat is the spectre of eugenics and the fear for the creation of an elite of genetically improved subjects, capable of prevaricating non-genetically modified humans. Concerns are so serious that some scholars have suggested the adoption of an international "Convention on the Preservation of the Human Species", 36 for the purpose of preserving the basic features of human nature which also underlie the human rights system. At the regional level, genetic identity finds protection in the Charter of Fundamental Rights of the European Union, 37 which sets "the prohibition of eugenic practices, in particular those 34 See GUNDERSON, M., "Enhancing Human Rights: How the Use of Human Rights Treaties to Prohibit Genetic Engineering Weakens Human Rights", cited above n. 27. ASHCROFT, R., "Genetic information and genetic identity", in THOMPSON, A. K., CHADWICK, R.F. (eds.), Genetic Information, Kluwer Academic, Plenum Publishing, New York, 1999. Also see: KLITZMAN, R., ""Am I my genes?": Questions of identity among individuals confronting genetic disease", Genetics in Medicine, n° 11(12), December 2009, pp. 880-889. 35 ANDORNO, R., "Biomedicine and international human rights law: in search of a global consensus", cited above n. 28. HIPP, J., ATALA, A., "Tissue engineering, stem cells, cloning, and parthenogenesis: new paradigms for therapy", Journal of Experimental and Clinical Assisted Reproduction, n° 1(3), 2004, available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC539246/pdf/1743-1050-1-3.pdf last accessed 14 October 2017. ANNAS, G., ANDREWS, L., ISASI, R., "Protecting the endangered human: toward an international treaty prohibiting cloning and inheritable alterations", American Journal of Law and Medicine, n° 28 (2-3), 2002, pp. 151-178. 36 See GUNDERSON, M., "Enhancing Human Rights: How the Use of Human Rights Treaties to Prohibit Genetic Engineering Weakens Human Rights", cited above n. 27. ANNAS, G., ANDREWS, L., ISASI, R., "Protecting the endangered human: toward an international treaty prohibiting cloning and inheritable alterations", cited above n. 35. aiming at the selection of persons" where it protects physical integrity while instrumentally safeguarding human dignity. In this regard, it is particularly significant here to stress that this provision finds correspondence and practical enforcement in EU's "Biotechnology Directive", where it "exclude[s] unequivocally from patentability processes for modifying the germ line genetic identity of human beings", as practices contrary to ordre public according to widespread Member States' consensus. 38 That being said, it is evident the human germline alterations affecting the body-size would not serve any preventive purpose, otherwise would address a trait that impacts on the core of genetic identity. 39 Once feasibility of genome editing is framed under international law and once the viability human germline cells alterations is ruled out, human somatic cells alterations for therapeutic purposes remains as a possible route to foster human adaptation to the challenges posed by climate change. In fact, human somatic cells alterations aimed at enhancing human traits, are excluded for analogous reasons, since the relevant international instruments only allow therapeutic interventions, including when they are preventive, and risks of eugenics and discrimination are similar. Indirect rejection of genome editing for purposes of enhancement can be found in above-mentioned Article 13 of the Oviedo Convention and in Article 12(b) of the Universal Declaration on Human Genome and Human Rights, which expressly clarifies that the application of research "shall seek to offer relief from suffering and improve the health of individuals and humankind as a whole". Furthermore, this study argues that epigenetics represents a See GUNDERSON, M., "Enhancing Human Rights: How the Use of Human Rights Treaties to Prohibit Genetic Engineering Weakens Human Rights", cited above n. 27. ASHCROFT, R., "Genetic information and genetic identity", cited above n. 34. Also see KLITZMAN, R., ""Am I my genes?": Questions of identity among individuals confronting genetic disease", cited above n. 34. For an in depthanalysis, see: ANNAS, G., ANDREWS, L., ISASI, R., "Protecting the endangered human: toward an international treaty prohibiting cloning and inheritable alterations", cited above n. 35. 
HUMAN RIGHTS: AN APPROPRIATE PARADIGM FOR GENOME EDITING AND EPIGENETICS AS SOLUTIONS TO COPE WITH CLIMATE CHANGE-RELATED CHALLENGES?
Human rights treaties have been used as suitable legal instruments to address climate change on several occasions: even if these tools are not expressly dedicated to environmental issues and sometimes they were adopted decades ago, in a different historical context, their nature of living instruments has enabled them to welcome environmental claims when connected to the entitlements they enshrine. Several examples can be found in the jurisprudence of some regional bodies. The European Court of Human Rights (ECtHR), 40 for example, has addressed the impact of the adverse effects of climate change on the right to life, the right to private and family life and the right to property; the Inter-American Commission on Human Rights (IACHR) 41 has granted protection to climate change-related instances concerning the preservation of the cultural identity, the traditions and the land of indigenous communities.
There are several reasons why international human rights law has become a suitable response to climate change. Firstly, because the adverse effects of climate change are capable of affecting the lives of individuals within States' borders, prejudicing the enjoyment of their rights; secondly, for the climatic implications on global public health, for example in relation to the dispersion of toxicants and the risks of epidemics or even pandemics. Last but not least, from a regulatory viewpoint, because climate change requires concerted action through international cooperation, and human rights offer a 'lowest common denominator', which helps to identify important shared standards of protection, both universally and regionally.
That being said, the point here is assessing whether and how international human rights law can provide accommodation for human beings' adaptation to climate change through biolegal solutions, namely therapeutic human somatic cells alterations and epigenetics.
Therapeutic interventions on human somatic cells were already put in practice with good results in the 1990s and early 2000s, to treat severe combined immunodeficiency (SCID). However, on other occasions in the same period the results were not as encouraging and even turned out to be lethal for the patient in the case of Jesse Gelsinger, who suffered from ornithine transcarbamylase (OTC) deficiency. 42 Epigenetics, that literally means "on tops" or "above" the genetics, 43 does not determine any alteration in the genotype of the subject interested, but merely affects the phenotype, since it alters gene activity but leaves gene sequence unchanged. Among the main examples of epigenetic interventions currently feasible, DNA methylation and chromatin modification can be cited. 44 There is scientific evidence that epigenetic interventions carried out on adult subjects are also transmissible to the progeny in a multigenerational and intergenerational fashion. 143 reversible, differently from human germline cells editing. 46 Epigenetics may represent a helpful solution for tackling the adverse effects of climate change on individuals in two ways: as a means for prevention of the onset of genetic diseases, by 'inhibiting' or in some ways intervening on gene's activity; again, as a means for elaborating therapeutic solutions to reverse an adverse epigenetic process once environmental conditions have triggered it. As to the first path advanced, innovative epigenetic-based diagnostic, preventive and therapeutic strategies may be suggested for coping with human diseases.
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As to the second application advanced, reversibility of alterations in the epigenome may be promoted through dietary responses, as the assumption of dietary phytochemicals and supplements, which could be very easily incorporated in daily life. In practice, interesting results were achieved through administration of epi-drugs, namely drugs that have been devised for inhibiting epigenetic enzymes, as it was the case for breast cancer.
48 Human epigenetic alterations are variously triggered by adverse environmental conditions related to climate change in our modern globalized and increasingly industrialized world, as dispersion of toxicants due to growing transport of pollution and legacy contaminants and changes in agricultural practices. 49 In literature, for example, inorganic arsenic was linked to DNA methylation. Exposure to environmental toxicants has a deleterious impact on human beings and there is growing evidence that links it to the onset of wide array of non-infectious diseases, as polycystic ovary syndrome (PCOS), germ cell apoptosis, increased risk of developing autism-spectrum disorders and pregnancy defects. Prenatal exposure to such environmental conditions is capable of dysregulating the fetal epigenome, which may lead up to the onset of diseases during early stages of life and to developmental disorders. 50 What is more, these conditions are capable of affecting in the long-term the epigenome of gametes, and thus would be passed on to the progeny. Early Epigenetics, thus, may help coping with a quite wide array of invalidating diseases and, even if there is evidence of transmissibility to the progeny of the results of its applications, they are likely to reconcile with the prohibition of human germline alterations for two reasons: firstly, because, as anticipated above, they would affect only the phenotype and not the genotype, and then they trigger a reversible process in genes' activity. Secondly, epigenetic interventions would not clash with the less rigorous conception of the right to genetic identity strict conception, as they would serve a therapeutic purpose.
Primary guidance for assessing whether and how interventions on human somatic cells and the use of epigenetics are viable solution to address adaptation to climate change under international human rights law is offered by the conception of human dignity and, from some viewpoints, by the notion of "dignified existence". Human dignity is a founding value in the field of human rights and, in particular, in the field of biolaw, where it plays a 'unifying' role that transcends and overcomes ethical relativism (ANDORNO, 2002, 961) . 52 Despite some scholars have claimed that it is a mere rhetorical conception, void of meaning, human dignity has globally affirmed as an absolute and unconditional value, all the more in the field of biolaw, where it has often provided the main parameter for assessing the admissibility of given scientific practices. Under international human rights law, human dignity may be intended in a twofold sense that echoes the Kantian conception, as "empowerment" and as "constraint". 53 In the latter case, human dignity is intended as a "constraint on autonomy", which is pre-eminently focused on duties in the interest of common good and which implies that biomedical practice should be led by a common vision of human dignity that transcends the individual sphere. Otherwise, human dignity as "empowerment" is focused on a human rights perspective, and requires the 51 DOLINOY, D.C., JIRTLE, R., "Environmental epigenomics in human health and disease", Environmental and Molecular Mutagenesis, n° 49(1), January 2008, pp. 4-8; GUERRERO-BOSAGNA C., JENSEN, P., "Globalization, climate change, and transgenerational epigenetic inheritance: will our descendants be at risk?", Clinical Epigenetics n° 7(1), 2015, pp. 8-13. 52 ANDORNO, R., "Biomedicine and international human rights law", cited above n. 28. BINDER, G., "Cultural Relativism and Cultural Imperialism in Human Rights Law", Buffalo Human Rights Law Review, n° 5, 1999, pp. 211-221; SPAAK, T., "Moral Relativism and Human Rights", Buffalo Human Rights Law Review, Vol. 13, 2007, available at https://papers.ssrn.com/sol3/papers.cfm?abstract_id=923445 last accessed 7 October 2017. From a wider perspective, for deepening the analysis: MORELLI, M., "El concepto del bioderecho y los derechos humanos", Vida y Ética, n° 1, año 11, 2010, pp. 194-222 . Also see: HERRERA FLORES, J., Los derechos humanos como productos culturales: Crítica del humanismo abstracto, Catarata, Madrid, 2005; NICKEL, J., REIDY, K., Relativism, Self-Determination, and Human Rights, available at http://web.utk.edu/~dreidy/nickelreidyfinaldraft2005.pdf last accessed 11 October 2017. 53 ANDORNO, R., "Dignidad Humana", Enciclopedia de Bioderecho y Bioética, available at http://enciclopedia-bioderecho.com/voces/120 last accessed 15 October 2017. fulfilment of the conditions necessary for the full development of human personality. International human rights bodies have relied on both conceptions of human dignity and, for our purposes, reference to their jurisprudence built upon the perspective of "empowerment" for the enjoyment of human rights is particularly significant for clarifying the suitable human-rights approach to consider.
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In this respect, it is interesting to recall the conception of vida digna, that is 'dignified existence', elaborated by the Inter-American Court of Human Rights (IACtHR), which represents a basic feature of the Court's approach to further elaboration of the standards of protection of the entitlements enshrined in the American Convention on Human Rights (ACHR). A dignified existence is intended as the unavoidable precondition for personal development, which allows the enjoyment of human rights, and applies transcendentally in the system of the Convention, as it was the case for Artavia Murillo v Costa Rica ruling, 55 the only decision adopted by the IACtHR in the field of biolaw. In that judgment, the Court held that the prohibition of in-vitro fertilization set by Costa Rica breached the right to privacy, the right to personal liberty, the right to physical, mental and moral integrity and the right to found a family protected under the ACHR. What is particularly significant here is that the Court recognized the right to access to given biomedical techniques, namely in-vitro fertilization, under the ACHR, by establishing that the rights to private life and to personal integrity are also directly and immediately linked to health care. From a wider viewpoint, in connection to human dignity and the conception of dignified life, the Court has affirmed the right to access to the highest attainable standards of health, including health care and assistance, treatment and medication, without any discrimination. 56 In Strasbourg, the European Court of Human Rights (ECtHR), that has developed a wide and settled jurisprudence in the field of biolaw, has relied on human dignity to ensure access to adequate health care, especially to persons under detention or imprisonment, under Article 3 of the European Convention on Human Rights (ECHR), which enshrines the prohibition of torture and inhuman and degrading treatment, and almost recognized the right to ensure continuing access to palliative care under the Convention in the case D. v the United Kingdom.
57 The case Aleksanyan v Russia 58 provides an example of the approach under consideration, especially where the Court relied on human dignity for finding that Russia had "failed to take sufficient care of the applicant's health to ensure that he did not suffer treatment contrary to Article 3 of the Convention". 59 In particular, the denial of access to appropriate health assistance and treatment constituted inhuman and degrading treatment, since it "undermined [the applicant's] dignity and entailed particularly acute hardship, causing suffering beyond that inevitably associated with a prison sentence and the illnesses he suffered from". 60 This view is not exceptional in the Strasbourg jurisprudence, otherwise it is widely restated in the Court's decisions, where denial of access to appropriate medical assistance and treatment amounts to a breach of the Convention. Moreover, although reference to human dignity is not generalized in this context, the ECtHR has recognized the right to timely access to amniocentesis and the right to access to abortion services under Article 8 of the Convention, occasionally in conjunction with Article 3 of the ECHR. 61 At the global level, "[e]very human being is entitled to the enjoyment of the highest attainable standard of health conducive to living a life in dignity" under Article 12 of the International Covenant on Economic, Social and Cultural Rights (ICESCR), 62 since "[h]ealth is a fundamental human right indispensable for the exercise of other human rights", as the Committee on Economic, Social and Cultural Rights has clarified in General Comment No. 14 on "The Right to the Highest Attainable Standard of Health". 63 It is interesting here to stress that the wording of Article 12 of the ICESCR, where it ensures the "highest attainable standards of physical and mental health", echoes the language of the Constitution of the World Health Organization (WHO) that defines "the highest attainable standard of health as a fundamental right of every human being". In practice, appropriate enforcement is fostered by the paradigm of the "4-A scheme", which helps to elucidate State obligations about the conditions for best enjoyment of the right. The "4-A scheme" hinges on availability, accessibility, acceptability and adaptability which turns into quality when health is at stake, and substantially entails that health services, goods and facilities, be made available in sufficient quantity ad be accessible without discrimination, physically, economically and informationally. Acceptability implies that health services, goods and facilities offered are consistent with medical ethics, and their good scientific and medical quality has to ensured.
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What can be inferred here is, firstly, that use of therapeutic human somatic cells interventions and of epigenetic-based diagnostic, preventive and therapeutic strategies is consistent with an empowering conception of human dignity, since they enable human beings to enjoy a dignified existence and the full personal development by improving their adaptation to adverse climate-change related environmental conditions capable of prejudicing their health and well-being. Secondly, what emerges is that access to therapeutic human somatic cells interventions and epigenetic-based diagnostic, preventive and therapeutic strategies can be claimed as an entitlement under international human rights law. This appears all the more arguable in light of the human rights framework of the European Union. The Charter of Fundamental Rights of the European Union and the "Biotechnology Directive" could be recalled in order to provide confirmation of the acceptability of therapeutic human somatic cells alterations and epigenetic-based diagnostic, preventive and therapeutic strategies. This may be argued especially when we consider that the Explanations concerning Article 3 of the Charter, which offer guidance on the scope of application of the provision, relate "eugenic practices" and the selection of persons to the reproductive sphere. In this regard, it may be advanced that the protection of physical integrity instrumentally to and in conjunction with human dignity allows practices intended to ensure "access" to medical processes 64 DONDERS, Y., "The right to enjoy the benefits of scientific progress: in search of state obligations in relation to health", Medicine, Health Care, and Philosophy, n° 14(4), November 2011, pp. 371-381. The Committee on Economic, Social and Cultural Rights has recalled and elucidated the concept of 'core obligations' in the following General Comments: General Comment no. 3 (1990) on the Nature of State Parties Obligations, para. 10; General Comment No. 12 (1999) on The Right to Adequate Food, para. 8; General Comment No. 13 (1999) on the Right to Education, para. 57; General Comment No. 14 (2000) on the Right to the Highest Attainable Standard of Health, para. 43-45. In this regard, guidance is offered also by Primary health care: report of the International Conference on Primary Health Care, Alma-Ata, USSR, 6-12 September 1978, jointly sponsored by the World Health Organization and the United Nations Children's Fund and by the UN COMMITTEE ON ECONOMIC, SOCIAL AND CULTURAL RIGHTS, GUIDELINES ON REPORTING QUESTIONS RELATING TO ARTICLE 12 OF THE CESCR, UN Doc. E/1991/23, pp. 88-110 , which also provides some indicators or benchmarks for assessing States' commitment to ensure the minimum level of health through their policy and resources management. aimed to enhance a dignified existence, keeping in mind that the conception of human dignity enshrined in the Charter, as authoritatively clarified in scholarship, refers to the born person and not to the human being.
65 Again, the view held above seems all the more arguable when it is considered that, under international human rights law, States are under an obligation to ensure the right to "enjoy the benefits of scientific progress and its applications" pursuant to Article 15 of the ICESCR. This provision had received little attention in the international landscape and was never recalled by international jurisprudence, neither through direct application nor as a legal support to interpretation of other clauses. 66 Notwithstanding this, Article 15 of the ICESCR is widely recognized as the international legal basis of the right to science, and in 2013 the efforts of the Committee on Economic, Social and Cultural Rights focused on the draft of a General Comment on the Right to Science and to Enjoy the Benefits of Scientific Progress. 67 However, while awaiting further elucidation from the Committee on Economic, Social and Cultural Rights, some guidance can be found by reference to the Travaux Préparatoires of Article 27 of the Universal Declaration of Human Rights (UDHR), 68 (MANCISIDOR, 2015, 2) . 69 The reference to the Universal Declaration of Human Rights, which is recalled in the Preamble of the ICESCR and has inspired the drafting of the Covenant along with many other international human rights treaties, is beneficial to elucidate the content of States' obligations concerning the right to science and to enjoy the benefits of scientific progress and its applications", in whose scope such innovative scientific advancements as bioengineering and epigenetics can be said to fall. In this respect, therefore, it may be argued that States are under an obligation of international human rights law to ensure active participation in and enjoyment of such biotechnologies as therapeutic human somatic cells interventions and epigenetic-based diagnostic, preventive and therapeutic strategies. This appears all the more true since Article 15 of the ICESCR, going beyond Article 27 of the Universal Declaration of Human Rights, provides that States, for achieving the full realization of the right to benefits of scientific progress and its applications, have the duty to take all the necessary steps "for the conservation, the development and the diffusion of science and culture" and the obligation "to respect the freedom indispensable for scientific research and creative activity", also through "international contacts and co-operation in the scientific and cultural fields". Furthermore, postulating a human right to benefit from such innovative scientific advances as therapeutic interventions on human somatic cells and epigenetic strategies is consistent with the requirements set by Article 15 of the Oviedo Convention, that Paragraph 90 of the Explanatory Report of the Convention on Article 13 recalls as enabling conditions of human somatic cell gene therapy, and with subsequent Paragraph 95 which, when elucidating the scope of Article 15 of the Oviedo Convention, clarifies that "freedom of scientific research in the field of biology and medicine is justified […] by the considerable progress its results may bring in terms of the health and well-being of patients". This last statement may arguably accommodate epigenetic-based diagnostic, preventive and therapeutic strategies, in line with the principle of the primacy of the human beings over the exclusive interests of science and society.
Providing accommodation for the promotion of human adaptation to climate change through a biolegal approach under international human rights law does not only mean to suggest a legal justification to this approach. It also allows to pave the way to justiciability of the violations to which individuals are victims, by enabling them to submit their complaints to international human rights bodies, either judicial or nonjudicial. This is all the more true since the Optional Protocol to the International Covenant on Economic, Social and Cultural Rights, 70 communications from individuals. This new competence is likely to help enhance the further evolution of international human rights law, especially when the advances in biolaw and biomedicine are at stake, as it enables the development of the Committee's jurisprudence on the right to science and to enjoy the benefits of scientific progress.
CONCLUSIONS
"We control life, Winston, at all its levels. You are imagining that there is something called human nature which will be outraged by what we do and will turn against us. But we create human nature."
Next year, these words will celebrate their seventieth anniversary. However, there is something always very modern in the caveat by which George Orwell addressed the mankind of the second post-war back in 1948, theorizing a society where the spirit of humanity had disappeared, defeated by arrogant and arbitrary tyranny of an élite headed by the Big Brother. The masterpiece "1984" wished to exorcise several dystopic fears of those times, descending from annihilation of the essence of humanity, which in the novel is subjugated to a totalitarian political dominion through brainwashing and destruction of self-autonomy.
The fear for losing the spirit of humanity has not vanished in our modern world, otherwise occasionally it seems to be enhanced by the power of science and progress we have conquered. Not only we fear that the outstanding scientific advances now available might turn against us, but we also feel vulnerable because, in spite of this progress, still we cannot cope with many of the unprecedented challenges we are called to face.
Climate change is one of them and everyone often feels unprepared, from the international community to scientists, and individuals in their daily life. But there is still a way out of this impasse: human rights. In a world of ethical relativism, human rights are capable of embodying unifying values, as they flow from the ultimate essence of man: human dignity, a universal and absolute value. In a reality of moral pluralism, we need to reaffirm human dignity, and bioethics and biolaw offer precious guidance for this purpose. Human germline alterations and human reproductive cloning are appealing practices, but the prohibition set on them by international biolaw in both binding and nonbinding tools looks like an attempt to preserve the dominion of nature over the echo of multigenerational and transgenerational life. This prohibition is rooted in the international landscape and in numerous domestic legal orders that felt compelled to affirm it expressly. Similarly, the international community twenty years ago felt compelled to explicitly set a conventional curb in the Oviedo and to enshrine the prohibition in a legal although non-binding instrument, the UNESCO's Universal Declaration on Human Genome and Human Rights, that conveyed the consensus of almost all countries in the world.
It is not necessary to have recourse to the 'Baxter paradox' to argue that it is still soon to claim that the prohibition of editing the genetics of future generations has become a rule of customary international law; nor it seems convincing that "cloning and inheritable genetic alterations can be seen as crimes against humanity", 71 as some scholars have claimed. Nonetheless, consensus is settled and nothing suggests a shift of perspective. The view changes when we focus on therapeutic human somatic cells alterations and epigenetic-based diagnostic, preventive and therapeutic strategies, which are not at odds with the principles of international biolaw and which could benefit human health and the enjoyment of a dignified existence. When innovative practices are allowed under international law, biolaw has proven capable of promoting the affirmation of scientific progress and translating it into human rights and corresponding States duties, as it was the case for in-vitro fertilization. Indeed, sometimes some scientific advances are not immediately welcomed but receive growing acceptance in time, as it was the case for in-vitro fertilization, for example. In this regard, international bodies interpreting biolaw can play a major role for providing guidance and shedding light on viability of given biotechnological advances, especially when life is concerned. The decisions issued by the European Court of Justice with regard to patentability of parthenogenic stem cells in the cases Brüstle v. Greenpeace and International Stem Cell v. Comptroller General of Patents, Designs and Trade Marks are emblematic and are all the more interesting as they impact on a regional reality characterized by a variety of approaches. In this respect, the expression "variable geometry" by which the European landscape on research on human embryos -ranging from permissive to lacking or indirect regulation -was addressed, is emblematic. It is not unusual that international biolaw is called to bridge the gaps between quite different national views; it accounts for the flexible formulation of international biolaw instruments, which do not aim at providing definitive responses, but embrace the existing principles for providing guidance to States through implementation, respectfully of peculiar domestic ethics. Clearly, this flexible structure also allows these tools to accommodate scientific progress and the innovations it brings. One of the reasons for which biolaw can provide suitable means for fighting climate change is that it can offer innovative responses, in a field where traditional means are often outdated or inappropriate. Globalization and scientific progress, indeed, have a huge impact on climate change and new technologies, capable to innovate but at the same time to be ethical and sustainable, are welcome. The ability to reconcile scientific advances and respect for ethics is another common feature to biolaw and international responses to climate change and this helps to explain the centrality of human rights in both contexts. This also accounts for the far-sighted perspective that ensures "due regard" to "the importance of appropriate access and utilization of biological and genetic resources" and "to "the role of human beings in the protection of the environment" in the UNESCO's 71 ANNAS, G., ANDREWS, L., ISASI, R., "Protecting the endangered human: toward an international treaty prohibiting cloning and inheritable alterations", cired above n. 35.
Universal Declaration on Bioethics and Human Rights. This perspective addresses future generations by protecting their genetic constitution from possible adverse impact of life sciences. This is further evidence of the viability of the human rights-based model suggested by this study, which could be briefly summed up by reference to the paradigm postulated by the African Commission on Human and People's Rights in in the case Social and Economic Rights Action Center (SERAC) and Center for Economic and Social Rights (CESR) v. Nigeria, which "subscribes to a rights-based and rights-framed model of development, one in which the goal of development activities is imagined, at least in part, as the fulfilment of the economic and social rights of a people". 72 This brief reference leads to the conclusive considerations, regarding the key role of States, which were appropriately defined as 'primary agents' in the realization of human rights. This is all the more true at the intersection of biolaw and climate change, where implementation of the guidance and the principles set at the international level necessarily require adequate national regulatory frameworks for enforcement. States cannot overlook that they are duty bound to protect, respect and fulfil human rights under international law, as it is the case for the right to health and the right to science and to enjoy the benefits of scientific progress, which are identified here as the suitable legal bases for accommodating the application of human somatic cells editing and epigenetics.
Conclusively, once again we can convey our view on a human rights-based approach to improve human adaptation to climate change through biolaw by recalling George Orwell's words on human nature.
Since human rights 'flow' from human dignity and convey the essence of human nature, similarly to Winston, the protagonist of '1984', we could reply to human rights sceptical by saying: "There is something in the universe -I don't know, some spirit, some principle -that you will never overcome". 
